WELCOME TO The HEALTHCARE REPORT
CURRENT AND EMERGING HEALTHCARE CYBER THREAT LANDSCAPE
March 24, 2022
2021 was a challenging year in cybersecurity with several high-profile compromises involving large vendors and large-scale vulnerabilities.
I'm For Real
Enter your details once to access all our information and resources
Amil is an iconic healthcare company in Brazil and is part of the UnitedHealth Group, the largest and most diversified healthcare group in the world, offering benefits and services in more than 130 countries to about 140 million people .
whitePaper | November 20, 2019
This whitepaper examines the financial implications of an effective CRM system, without which your organization risks. To acquire and retain patients, health systems have to connect with their customers cost-effectively. And along the way, they need to detect and measure to what extent their marketing efforts are making an impact.
whitePaper | April 6, 2021
Delivering quality care to patients requires much more than just good intentions. Healthcare providers must respond to constantly evolving technological, financial and security challenges with digital infrastructure that can meet their needs. Learn about a platform solution built to succeed in the modern healthcare landscape.
whitePaper | May 20, 2022
Starting your own telemedicine practice or expanding your virtual care services? With the telehealth transformation underway,
whitePaper | February 15, 2022
Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.
whitePaper | January 27, 2023
Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.
whitePaper | February 10, 2022
Reimagining Healthcare in India through Blended Finance
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE